Europe Cancer Registry Software Market Size & Outlook
The cancer registry software market in Europe is expected to reach a projected revenue of US$ 37.9 million by 2030. A compound annual growth rate of 11.6% is expected of Europe cancer registry software market from 2024 to 2030.
Revenue, 2023 (US$M)
$17.6
Forecast, 2030 (US$M)
$37.9
CAGR, 2024 - 2030
11.6%
Report Coverage
Europe
Europe cancer registry software market, 2018-2030 (US$M)
Related Markets
Europe cancer registry software market highlights
- The Europe cancer registry software market generated a revenue of USD 17.6 million in 2023.
- The market is expected to grow at a CAGR of 11.6% from 2024 to 2030.
- In terms of segment, standalone was the largest revenue generating software in 2023.
- Standalone is the most lucrative software segment registering the fastest growth during the forecast period.
- Country-wise, Sweden is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 17.6 million |
| Market revenue in 2030 | USD 37.9 million |
| Growth rate | 11.6% (CAGR from 2023 to 2030) |
| Largest segment | Standalone |
| Fastest growing segment | Standalone |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Standalone, Integrated |
| Key market players worldwide | Elekta AB ADR, Health Catalyst Inc, Onconetix Inc, McKesson Corp, Rocky Mountain High Brands Inc, C/NET Solutions |
Other key industry trends
- In terms of revenue, Europe region accounted for 23.2% of the global cancer registry software market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 47.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Registry Software Market Scope
Cancer registry software market segmentation & scope
Cancer Registry Software Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe cancer registry software market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cancer registry software market will help companies and investors design strategic landscapes.
Standalone was the largest segment with a revenue share of 80.68% in 2023. Horizon Databook has segmented the Europe cancer registry software market based on standalone, integrated covering the revenue growth of each sub-segment from 2018 to 2030.
- Europe Cancer Registry Software Software Outlook (Revenue, USD Million, 2018-2030)
- Standalone
- Integrated
- Europe Cancer Registry Software Deployment Model Outlook (Revenue, USD Million, 2018-2030)
- On-Premise
- Cloud Based
- Europe Cancer Registry Software Component Outlook (Revenue, USD Million, 2018-2030)
- Commercial
- Public
- Europe Cancer Registry Software End-Use Outlook (Revenue, USD Million, 2018-2030)
- Government & Third Party
- Private Payers
- Hospital & Medical Practise
- Pharma Biotech & Medical Device Companies
- Research Institutes
Reasons to subscribe to Europe cancer registry software market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe cancer registry software market databook
-
Our clientele includes a mix of cancer registry software market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe cancer registry software market, including forecasts for subscribers. This continent databook contains high-level insights into Europe cancer registry software market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe cancer registry software market size, by country, 2014-2030 (US$M)
Europe Cancer Registry Software Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
